论文信息 - In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS) - 字舞流文

In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS)

C. Simone | S. Di Tommaso | A. Selicorni | D. Melis | M. Ruggieri | G. Abbadessa | N. Resta | F. Susca | A. Peserico | M. Lerone | A. Bartuli | R. Bagnulo | A. Praticò | P. Sanese | G. Forte | V. Grossi | B. Schwartz | A. De Luisi | C. Ranieri | D. Loconte | Y. Yu